Clinical Trial Update: Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

The document reports on a Phase 3 clinical trial evaluating gemcitabine and carboplatin followed by docetaxel for stage IIIB or stage IV non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED